Pharsight

Skyepharma Ag patents expiration

1. Triglide patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6696084 SKYEPHARMA AG Spray drying process and compositions of fenofibrate
Sep, 2021

(2 years ago)

Drugs and Companies using FENOFIBRATE ingredient

Market Authorisation Date: 07 May, 2005

Treatment: A method of treating dyslipidemia and dyslipoproteinemia using a dosage form that can provide an effective amount of fenofibrate to a patient in a fasted state which is at least 90% of the auc amount ...

Dosage: TABLET;ORAL

More Information on Dosage

TRIGLIDE family patents

Family Patents